| Date Filed | Type | Description |
| 02/17/2015 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 0% stake in LipoScience, Inc. |
| 02/17/2015 |
SC 13G/A
| Flynn James E reports a 0% stake in LipoScience, Inc. |
| 02/12/2015 |
SC 13G
| SightLine Healthcare Management III, L.P. reports a 0% stake in LipoScience, Inc. |
| 02/12/2015 |
SC 13G/A
| GARDNER LEWIS ASSET MANAGEMENT L P reports a 0% stake in LipoScience Inc |
| 11/25/2014 |
8-K/A
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits |
| 11/24/2014 |
SC 13D/A
| LABORATORY CORP OF AMERICA HOLDINGS reports a 100% stake in LipoScience, Inc. |
| 11/21/2014 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 11/12/2014 |
10-Q
| Quarterly Report for the period ended September 30, 2014 |
| 11/12/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 11/12/2014 |
8-K
| Quarterly results |
| 11/10/2014 |
SC 13G
| GARDNER LEWIS ASSET MANAGEMENT L P reports a 16.5% stake in LipoScience Inc |
| 11/10/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 10/27/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 10/20/2014 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 10/15/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 10/15/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 10/03/2014 |
SC 13D
| LABORATORY CORP OF AMERICA HOLDINGS reports a 17.7% stake in LipoScience, Inc. |
| 09/26/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 09/25/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 09/25/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 09/25/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 09/25/2014 |
8-K
| Acquisition/merger/asset purchase announced |
| 09/25/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 08/13/2014 |
10-Q
| Quarterly Report for the period ended June 30, 2014 |
| 08/12/2014 |
8-K
| Quarterly results |
| 07/01/2014 |
10-K/A
| Annual Report for the period ended December 31, 2013 [amend] |
| 06/12/2014 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/15/2014 |
10-Q
| Quarterly Report for the period ended March 31, 2014 |
| 05/12/2014 |
8-K
| Quarterly results |
| 05/05/2014 |
8-K
| Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm... |
| 04/29/2014 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 03/28/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 03/20/2014 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 5.2% stake in LipoScience, Inc. |
| 03/14/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|